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Although activation of muscarinic cholinergic receptors on 1321N1 human astrocytoma cells results in a
linear accumulation of inositol phosphates for up to 60 min in the presence of LiCl [Masters, Quinn & Brown
(1985) Mol. Pharmacol. 27, 325-332], activation of H1-histamine receptors resulted in an increase in total
inositol phosphate formation that was maintained for less than 5 min. The effects of stimulation of these
two receptors on accumulation of inositol 1,4,5-trisphosphate [Ins(1,4,5)P3J, inositol 1,3,4-trisphosphate
[Ins(1,3,4)P3] and inositol 1,3,4,5-tetrakisphosphate [Ins(1,3,4,5)P4] were also examined. Incubation of
1321N1 cells with carbachol resulted in a rapid accumulation of all three inositol phosphates, reaching a
maximum within 30 s; this elevated value was maintained for up to 60 min. The rate of disappearance of
Ins(1,3,4)P3 from carbachol-treated cells after the addition of atropine paralleled or exceeded the rate of
disappearance of Ins(1,4,5)P3. Although the initial rates of accumulation of Ins(1,4,5)P3, Ins(1,3,4)P3 and
Ins(1,3,4,5)P4 in the presence ofhistamine were similar to that observed with carbachol, the amounts of these
inositol phosphates had returned to control values within 5 min after the addition of histamine. The results
indicate that, although the acute effects of muscarinic receptor and H,-histamine receptor stimulation on
phosphoinositide hydrolysis are very similar, the histamine receptor is desensitized rapidly, whereas the
muscarinic receptor is not. This effect on histamine-receptor function is apparently homologous, since
preincubation of 132INI cells with histamine did not decrease the subsequent response to carbachol.
INTRODUCTION
Ca2+-mobilizing hormones activate a phospholipase C
(Michell, 1975) that catalyses formation of the cellular
second messengers Ins(1,4,5)P3 (Berridge et al., 1983;
Berridge & Irvine, 1984) and diacylglycerol (Nishizuka,
1984) from polyphosphoinositides. Ins(1,4,5)P3 ap-
parently mobilizes Ca2+ from endoplasmic reticulum
(Streb et al., 1983; Berridge & Irvine, 1984), whereas
diacylglycerol acts, in concert with Ca2+, as the
endogenous activator of protein kinase C. Although this
scheme of second-messenger action is in general
supported by data obtained with a number of hormone
receptors and many target tissues, neither the details of
formation and metabolism of the phosphoinositide
hydrolysis products nor identification of their intra-
cellular sites of action has been fully established. Irvine
et al. (1984, 1985) have reported that a second InsP
isomer, Ins(1,3,4)P3, accumulated in rat parotid gland
after carbachol stimulation. However, the kinetics of ap-
pearance and disappearance of the two InsP3 isomers
were markedly different. That is, whereas the accumu-
lation and degradation of Ins(1,4,5)P3 were rapid,
Ins(1,3,4)P3 accumulated with a lag, eventually attained
much higher concentrations than Ins(1,4,5)P3, and dis-
appeared more slowly after cessation of hormonal
challenge than did Ins(1,4,5)P3 (Irvine et al., 1985).
Similar results have been reported by Burgess et al. (1985)
for guinea-pig hepatocytes, pancreatic acinar cells and
dimethyl sulphoxide-differentiated human myelomono-
cytic HL-60 leukaemia cells. The physiological impor-
tance of Ins(1,3,4)P3 has not been defined. However, on
the basis of its relatively slow rates of formation and
disappearance, it has been proposed that this inositol
phosphate does not subserve a role in the initial Ca2+-
mobilizing effects of hormones.
The mechanisms of synthesis and degradation of
Ins(1,3,4)P3 also have not been defined fully. However,
Batty et al. (1985) and Irvine et al. (1986) have reported
the existence of Ins(1,3,4,5)P4 in mammalian tissues. Ins-
(1,4,5)P3 is apparently converted into Ins(1,3,4,5)P4 by a
specific Ins(1,4,5)P3 3-kinase (Irvine et al., 1986), and the
5-dephosphorylation of this inositol tetrakisphosphate
probably accounts for the occurrence of Ins(1,3,4)P3. In
most tissues the kinetics of accumulation of Ins(1,4,5)P3
and Ins(1,3,4)P3 after hormonal challenge are consistent
with this hypothesis; however, extensive data in support
of this proposal are not yet available.
132INI human astrocytoma cells have proved to be a
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useful model for the study of receptor-mediated
regulation of phosphoinositide turnover. Activation of
muscarinic cholinergic (Masters et al., 1984) and
histamine (Nakahata et al., 1986) receptors on these cells
results in an increase in inositol phosphate formation,
Ca2+ mobilization and cyclic AMP phosphodiesterase
activity. Although the formation of InsP3 in response to
both cholinergic stimuli (Masters et al., 1985a) and
histamine (Nakahata et al., 1986) has been documented
in these cells, the relative contribution of the two InsP3
isomers to this response has not been established.
Furthermore, although the formation of total inositol
phosphates is linear with time for 1 h in response to
carbachol (Masters et al., 1985a), in preliminary
experiments we observed that the response to histamine
was lost rapidly. In the current study we compare the
formation of inositol phosphates in response to both
muscarinic- and histamine-receptor stimulation.
MATERIALS AND METHODS
Materials
DMEM, EMEM, trypsin and fetal-calf serum were
purchased from Grand Island Biological Co. (Grand
Island, NY, U.S.A.). Carbachol, histamine, atropine,
ATP, ADP, AMP and ammonium formate were
obtained from Sigma Chemical Co. (St. Louis, MO,
U.S.A.). H3PO4 (h.p.l.c. grade) was from Fisher
Scientific Co. (Fair Lawn, NJ, U.S.A.). myo-[3H]Inositol
was purchased from New England Nuclear (Boston,
MA, U.S.A.) or American Radiolabeled Chemicals
(St. Louis, MO, U.S.A.), and myo-[3H]inositol 1,4,5-tris-
phosphate (1 Ci/mmol) was obtained from Amersham.
All chemicals and drugs were of reagent grade or the
highest quality available.
Cell culture
1321Nl human astrocytoma cells were grown in 35mm
dishes with DMEM containing penicillin (50 units/ml)
and streptomycin (50 mg/ml) as previously described
(Meeker & Harden, 1982).
Analyses of inositol phosphates
The cells were labelled overnight with 1-10#,Ci of
[3H]inositol/ml of inositol-free DMEM. After labelling,
the cells were washed twice with 1.5 ml ofEMEM/Hepes
(25 mM) and incubated in the same buffer for an
additional 10 min. Agonists were added for the indicated
times, and the reactions terminated by aspiration of the
medium and addition of 0.5 ml of methanol (for total
inositol phosphate assays) or 0.5 ml of 5% (v/v)
trichloroacetic acid (for h.p.l.c. assays). The cells were
scraped and rinsed with 0.5 ml of methanol (for assay of
total inositol phosphates) or 0.5 ml of 5% trichloroacetic
acid (for h.p.l.c. assays). Trichloroacetic acid extracts
were centrifuged and the supernatants were stored at
-20 'C. For assay of total inositol phosphates, the
pooled methanol fraction (1 ml) was combined with
chloroform (1 ml) and water (0.9 ml). After centrifuga-
tion the upper phase was applied to a column containing
1 ml bed volume of resin (AG 1-X8; 100-200 mesh,
formate form; Bio-Rad). Free inositol and glycero-
phosphate were eluted with 10 ml of water and 10 ml
of 50 mM-ammonium formate respectively. Total inositol
phosphates (InsPj, InsP2 and InsP3) then were eluted with
8 ml of 1.0 M-ammonium formate/100 mM-formic acid.
Preparation of 32P-labelled Ins(1,4,5)P3 from human
erythrocyte ghosts
This was done by the procedure of Downes & Michell
(1981). Blood (10 ml) obtained from a volunteer, with
5 mm-EDTA used as an anticoagulant, was centrifuged,
and plasma and leucocytes were carefully removed by
aspiration. The erythrocyte pellet was washed three times
with 154 mM-NaCl/ 1.5 mM-Hepes, pH 7.2. The washed
erythrocytes were incubated at 37 °C for 2 h in a buffer
containing 30,Ci of [32P]P1/ml, 136.9 mM-NaCl,
2.7 mM-KCl, 1.8 mM-CaCl2, 1.0 mM-MgCl2, 11.9 mM-
NaHCO3, 5.5 mM-glucose and 10 mM-Hepes, pH 7.4.
Erythrocyte ghosts were isolated by lysis with 20 mM-
Tris/I mM-EDTA, pH 7.4, washed three times with
20 mM-Tris/ 1 mM-EDTA, pH 7.4, and suspended in 5 ml
of 20 mM-Tris, pH 7.4, without EDTA. The suspended
erythrocyte ghosts were incubated with 1 mM-Ca2+ at
37 °C for 15 min, and the reaction was terminated by
addition of 5 ml of 10% trichloroacetic acid. After
centrifugation, the supernatant was stored at -20 °C
until use.
Preparation of 3H-labelled Ins(1,3,4)P3 from rat parotid
gland
Rat parotid glands were removed, minced with
scissors, and chopped with a McIlwain tissue chopper.
After several washes with inositol-free DMEM/Hepes
medium, phospholipids were labelled at 37 °C for 90 min
in S ml of inositol-free DMEM containing 8,Ci of
[3H]inositol/ml. The slices were washed with EMEM/
Hepes buffer and incubated for an additional 60 min at
37 'C. The slices were washed again with EMEM/Hepes
buffer and challenged with 1 mM-carbachol at 37 'C for
15 min in the presence of 10 mM-LiCl. The reaction was
terminated by addition of an equal volume of 10%
trichloroacetic acid, the samples were centrifuged, and
the supernatant fraction was kept for h.p.l.c. analysis.
Preparation of cytosol fractions from rat brain and
1321N1 cells
A whole rat brain was carefully removed, washed with
0.15 M-sucrose, and homogenized in 50 vol. of 0.15 M-
sucrose with a Teflon/glass homogenizer. The homo-
genate was centrifuged at 45000 g for 15 min, and the
supernatant was decanted and stored at -20 'C. 1321N1
cells were washed three times with 0.15 M-sucrose, the
surface was scraped, and the suspended cells were
homogenized in 0.5 ml of 0.15 M-sucrose by using 20
strokes of a Teflon/glass homogenizer. The cytosol
fraction was obtained by centrifugation at 15600 g for
5 min.
Determination of InsP3 isomers by h.p.l.c.
InsP3 isomers were analysed by the method of Irvine
et al. (1985). The samples (approx. 1 ml) were washed
four times with diethyl ether to remove trichloroacetic
acid, and injected into a Waters h.p.l.c. system equipped
with a Whatman Partisil SAX 10 anion-exchange column
(4.6 mm x 250 mm) equilibrated with water and main-
tained at a flow rate of 1.25 ml/min. ATP, ADP and
AMP (5 nmol of each) were used as u.v. markers. The
injection ofsamples was followed by a 5 min flow ofwater
and a 24 min flow of a linear gradient of 0-1.0 M-
ammonium formate (pH 3.7) buffered by H3P04 (AF/P
buffer). After a 6 min flow (29-35 min ofelution) ofAF/P
buffer (1.0 M), the eluent was changed to water and
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elution was continued for the following 17 min (35-52 min
of elution) before the next sample was injected. Eluates
were collected at 1 min intervals for the first 30 min and
at 0.3 min intervals after 30 min. A modified programme
of elution was used when only InsP3 isomers were
measured. After injection of the sample, the concentra-
tion ofAF/P buffer was increased to 0.71 M. After 6 min,
the concentration of AF/P buffer was increased linearly
to 1.0 M until 13 min, and elution with 1.0 M buffer
maintained until 20 min. After that, the eluent was
changed to water (20-22 min), and water was allowed to
flow for 5 min (22-27 min) before the next sample was
injected. When the modified elution pattern was used, the
eluates were collected at 0.3 min intervals beginning
1 min before the elution of ATP. The retention times of
inositol phosphates and adenine nucleotides gradually
changed during repeated use of the h.p.l.c. columns.
Therefore, the retention times of adenine nucleotides
were checked each day before injection of radio-
labelled inositol phosphates.
Determination of InsP4 by h.p.l.c.
In experiments designed to detect the formation of
InsP4, the linear gradient used for InsP3 elution was
extended to 1.8 M-ammonium formate buffered by
H3PO4 (pH 3.7). After the sample was injected, water
was passed through the column for 5 min, and then a
linear gradient of 0-1.8 M-AF/P buffer was passed within
43 min (5-48 min of elution). Elution was maintained
with 1.8 M-AF/P buffer for 5 min (48-53 min), and
linearly changed to water (53-57 min). Water was passed
through the column for an additional 8 min (57-65 min)
before a new sample was injected. The eluate was
collected at 0.3 min intervals for InsP3 isomers and at
1 min intervals of InsP4. A modified programme of
elution was used when both InsP3 isomers and InsP4
were measured. After injection of the sample, the
concentration of AF/P buffer was increased to 0.7 M.
After 6 min, the concentration of AF/P buffer was
increased linearly to 1.8 M until 32 min, and the elution
with 1.8 M buffer maintained until 37 min. The eluent
then was changed to water.
RESULTS
As reported previously by Masters et al. (1985a),
exposure of 1321N1 cells to carbachol results in a linear
accumulation of inositol phosphates for 60 min (Fig. 1).
In contrast, exposure of 132IN1 cells to histamine
resulted in a marked increase in inositol phosphate
accumulation during the first 1 min, but thereafter
histamine produced only a small effect relative to
carbachol (Fig. 1). Addition of fresh histamine to cells
previously exposed to histamine for 15 min caused no
further increase in inositol phosphate formation (Fig. 1,
inset). In contrast, addition of carbachol to histamine-
pretreated cultures resulted in inositol phosphate ac-
cumulation at a rate at least as rapid as that observed
during incubation with carbachol alone (Fig. 1, inset).
Measurement oftotal inositol phosphate accumulation
in the presence of LiCl obviously does not provide a
complete analysis of the relative capacity of carbachol
and histamine to stimulate phosphoinositide breakdown.
Since carbachol and histamine initially stimulate Ca2+
mobilization and Ca2+-calmodulin-sensitive cyclic AMP
phosphodiesterase to a similar extent in 132IN1 cells
(Nakahata et al., 1986), the relative effectiveness of these
agonists for stimulation of accumulation of Ins(1,4,5)P3
was compared.
The h.p.l.c. method of Irvine et al. (1985) was used to
separate InsP3 isomers. The elution pattern of inositol
compounds isolated from carbachol-stimulated 1321NI
cells was similar to that previously reported for rat
parotid gland (Irvine et al., 1985). In the elution profile
illustrated in Fig. 2, most of the radioactivity was in the
form of four major radioactive peaks. On the basis of the
similarity of the retention times of these radioactive
species to those of the inositol compounds in the report
by Irvine et al. (1985), as well as their positions relative
to standards of AMP, ADP, and ATP, these peaks of
radioactive compounds apparently consisted predomin-
antly of free inositol (peak A), Gro-PIns (peak B), InsP1
(peak C), InsP2 (peak D) and Gro-PInsP2 (peak E). In
this experiment very little radioactivity was eluted with
a retention time similar to that of ATP. However,
expansion of the ordinate (inset, Fig. 2) illustrates that
two peaks of radioactivity were eluted in this region. In
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Fig. 1. Accumulation of total inositol phosphates in response to
carbachol and histamine in 1321N1 cells
Cells were labelled overnight with 1 ,uCi of [3H]inositol/ml,
washed with EMEM/Hepes and incubated with 1 mm-
carbachol (-), 1 mM-histamine (-) or vehicle (A) for the
indicated times. Data are presented as the accumulation of
total inositol phosphates with time, and are means + S.E.M.
for triplicate dishes. Similar results were obtained in three
experiments. Inset: cells were incubated with 1 mm-
histamine (0) or 1 mM-carbachol (A) for 15 min. Fresh
histamine (1 mM; 0) or carbachol (1 mM; A) was then
added to the histamine-pretreated cells, and total inositol
phosphate accumulation (ordinate) measured at the
indicated times. The data are the means of triplicate























Fig. 2. H.p.l.c. elution profile of 13Hlinositol compounds
1321N1 cells were labelled overnight with 5 uCi of [3H]inositol/ml. The cells were incubated with 1 mM-carbachol for 1 min
in the absence of LiCI, and the incubation was terminated by addition of 0.5 ml of 5% trichloroacetic acid. Trichloroacetic acid
was removed by four washes with diethyl ether, and ether was removed by a stream of N2 gas. Then 1 ml of the sample was
injected with ATP, ADP and AMP as described in the Materials and methods section. The retention time of each marker is
indicated by the arrows. Inset: some of the same data are shown in an expanded scale. Peaks A, B, C, D, E, F and G correspond
to inositol, Gro-PIns, InsPl, InsP2, Gro-PInsP2, Ins(1,3,4)P3 and Ins(1,4,5)P3 respectively.
prominent, and a comparison of their elution profile with
that of inositol phosphates isolated from human
erythrocytes and rat parotid is presented. It has been
reported previously that Ins(1,3,4)P3 is co-eluted with
ATP (Irvine et al., 1985). A peak of radioactivity from
carbachol-treated 1321N1 cells is co-eluted with ATP,
and with a concentration of ammonium formate and a
retention time similar to that previously reported for
Ins(1,3,4)P3 (Irvine et al., 1985). Since parotid glands
stimulated with carbachol under the conditions described
in the Materials and methods section predominantly
contain Ins(1,3,4)P3 (Irvine et al., 1984), the data
presented in Fig. 3(c) also support the tentative identity
of the first radioactive species illustrated in this elution
profile. That is, this compound(s) is co-eluted with the
predominant InsP3 isomer from parotid. Irvine et al.
(1985) reported that Ins(1,4,5)P3 was eluted with a
somewhat greater retention time than ATP and
Ins(1,3,4)P3. In addition, Downes & Michell (1981) have
reported that stimulation of erythrocyte ghosts with Ca2+
produces large amounts of Ins(1,4,5)P3. Thus the
retention time of the second radioactive species in Fig. 3
and its coelution with InsP3 from human erythrocytes are
consistent with its identity as Ins(1,4,5)P3.
In the absence of carbachol or histamine, little if any
radioactivity could be detected in 1321N1 cells as the
species tentatively identified as Ins(1,3,4)P3 (Fig. 4); a
prominent peak of radioactivity was eluted as the species
tentatively identified as Ins(1,4,5)P3. Addition of carba-
chol or histamine resulted in a rapid increase in the
amount of each species (Figs. 4 and 5). In contrast with
the results obtained with rat parotid gland (Irvine et al.,
1985), both InsP3 isomers accumulated with similar
kinetics in the presence of each agonist. Maximal values
were attained for each isomer with each agonist within
30 s. Ins(1,4,5)P3 and Ins(1,3,4)P3 contents remained
elevated for at least 60 min ofexposure to carbachol (Fig.
5, and results not shown). In contrast, the amounts of
both InsP3 isomers returned to control values within
5 min of exposure to histamine. The data suggest that
desensitization to the effects of histamine on Ins(1,4,5)P3
and Ins(1,3,4)P3 accumulation occurs rapidly, whereas
muscarinic-receptor-mediated increases in InsP3 forma-
tion are maintained during prolonged exposure to
agonists.
The disappearance of Ins(1,4,5)P3 and Ins(1,3,4)P3
also was examined in 1321N1 cells after cessation of
hormone stimulation. As previously illustrated (Fig. 5),
Ins(1,4,5)P3 and Ins(1,3,4)P3 were significantly increased
during a 5 min challenge with carbachol; contents
rapidly declined after the addition of 10 /M-atropine
(Fig. 6). Although some variability was observed, in
three out of four experiments the rate of disappearance
of Ins(1,3,4)P3 was more rapid than that of Ins(1,4,5)P3.
On the basis of the proposal that Ins(1,3,4)P3 may be
derived from Ins(1,3,4,5)P4 (Batty et al., 1985; Irvine
et al., 1986), the potential presence of Ins(1,3,4,5)P4 was
examined in 1321N1 cells. Irvine et al. (1986) have
demonstrated that [3H]Ins(1,4,5)P3 can be converted into
[3H]Ins(1,3,4,5)P4 by an Ins(1,4,5)P3 3-kinase in rat brain
cytosol. In support of the data of Irvine et al. (1986),
incubation of [3H]Ins(1,4,5)P3 with a cytosol fraction
obtained from rat brain resulted in conversion into a
radioactive species exhibiting h.p.l.c. elution properties
similar to those previously described for Ins(1,3,4,5)P4
(Fig. 7). Incubation of [3H]Ins(1,4,5)P3 with cytosol
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Fig. 3. Characterization of InsP3 isomers in 1321N1 cells
H.p.l.c. elution of [3HJinositol phosphates was as described
in the Materials and methods section. Data are presented
for fractions collected at 0.3 min intervals, beginning
30 min after injection of samples. The retention time of
standard ATP co-injected with sample A is indicated. The
results are representative of those obtained in four such
comparisons. (a) 1321N1 cells were labelled overnight with
Ci of [3H]inositol/ml. The cells were incubated with
carbachol (1 mM) for 1 min in the absence of LiCl. (b) A
[3H]inositol phosphate sample from carbachol-stimulated
1 321N1 cells was combined with an inositol [32P]phosphate
sample prepared from human erythrocyte ghosts as
described in the Materials and methods section. The
combined sample was injected and h.p.l.c. elution carried
out as described in the Materials and methods section. (c)
A [3H]inositol phosphate fraction was prepared from rat
parotid and subjected to h.p.l.c. ion-exchange chromato-
graphy as described in the Materials and methods section.
obtained from 1321N1 cells also resulted in appearance
of a radioactive species exhibiting the same retention
time (Fig. 7c). Moreover, this radioactive species was
observed in intact 1321N1 cells after incubation with
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Fig. 4. Time-dependent accumulation of InsP3 isomers in
carbachol-stimulated 1321N1 cells
Cells were labelled overnight with 10 ,Ci of
[3H]inositol/ml. The cells were incubated with 1 mM-
carbachol for 5 s to 5 min in the absence of LiCl.
Incubation was terminated by addition of 5% trichloro-
acetic acid, and h.p.l.c. elution of [3H]inositol phosphates
was carried out as described in the Materials and methods
section. Data are presented for fractions collected at
0.3 min intervals, beginning 18 min after injection of
samples. The results are representative of those obtained
in four experiments. Arrows in the top left-hand panel
indicate positions of Ins(1,3,4)P3 and Ins(1,4,5)P3.
co-elution during h.p.l.c. ion-exchange chromatography
with the radioactive species produced by incubation of
[3H]Ins(1,4,5)P3 with rat brain cytosol, we have tenta-
tively identified this product as Ins(1,3,4,5)P4. Its
identity as Ins(1,3,4,5)P4 is further supported by the
observation that, during extended incubation of 1321N1
cell or brain homogenate with [3H]Ins( 1 ,4,5)P3, a
radioactive species exhibiting the elution properties of
Ins(1,3,4)P3 was formed (results not shown). As
illustrated in Fig. 8, the compound identified as
Ins(1,3,4,5)P4 was present in non-stimulated 1321N1
cells, and its concentration was increased by approx.
3-fold in the presence of 1 mM-carbachol. The time
course of accumulation of Ins(1,3,4,5)P4 was essentially
identical with that of Ins(1,4,5)P3 measured in the same
cells (Fig. 8). Atropine blocked the effects of carbachol
on the accumulation of Ins(l,3,4,5)P4 (results not
shown). Histamine stimulated a 2-3-fold increase in
Ins(1,3,4,5)P4 accumulation that was maximal within
30 s and that, in contrast with the effects of carbachol,
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Fig. 5. Time course of accumulation of InsP3 isomers in the
presence of carbachol and histamine
1321N1 cells were labelled overnight with 10 ,uCi of
[3HJinositol/ml. The cells were incubated for the indicated
time in the absence of LiCl, and the reaction was
terminated by addition of0.5 ml of5% trichloroacetic acid.
InsP3 isomers were separated by h.p.l.c. by the modified
elution protocol described in the Materials and methods
section. Ins(1,4,5)P3 (0) and Ins(1,3,4)P3 (A) were
quantified by pooling the fractions corresponding to each
InsP3 isomer. Amounts of Ins(1,4,5)P3 (0) and
Ins(1,3,4)P3 (A) in the absence of added drug are also
indicated. Each point represents the mean+ S.E.M. for three
or four dishes; the results are similar to those obtained in
three separate experiments.
DISCUSSION
The kinetics of accumulation of Ins(1,4,5)P3 in
1321NI cells in response to both histamine and
carbachol are consistent with the proposed role of this
inositol phosphate as the receptor-regulated second
messenger involved in mobilization of intracellular Ca2 .
Intracellular Ca2+ concentration measured with Quin2 in
intact 1321N1 cells (J. R. Hepler & T. K. Harden,
unpublished work) increased with a time course similar
to that for Ins(1,4,5)P3, and, as with Ins(1,4,5)P3, Ca2+
concentrations reached a maximum within approx. 30 s.
In contrast, the kinetics of accumulation of Ins(1,3,4)P3
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Fig. 6. InsP3 contents after addition of atropine to carbachol-
stimulated 1321N1 cells
Cells were labelled overnight with 10 ,uCi of
[3H]inositol/ml. The cells were incubated for 5 min with
1 mM-carbachol. Atropine (10 /,M) was then added to the
medium and incubation continued for the indicated times.
The amounts of Ins(1,4,5)P3 (0, *) and Ins(1,3,4)P3 (A,
A) were determined by h.p.l.c. analysis of samples taken
before (0, A) or after (0, A) the addition of atropine.
The data are means + S.E.M. for three dishes, and are
representative of results obtained in three separate
experiments.
were surprising. That is, Ins(1,3,4)P3 accumulated with a
time course essentially the same as that of Ins(1,4,5)P3.
Furthermore, on addition of atropine, Ins(1,3,4)P3
disappeared as fast as, if not faster than, Ins(1,4,5)P3.
Although the physiological role of Ins(1,3,4)P3 is not
known, its relatively slow rate of appearance and
disappearance in other target tissues has not been
compellingly appropriate for a role of this inositol
phosphate in hormone-stimulated Ca2+ mobilization.
This point cannot be made for 1321N1 cells, where the
time courses of accumulation and disappearance of
Ins(1,3,4)P3 are very similar to those of Ins(l,4,5)P3 and
intracellular Ca2 . It also should be emphasized that the
fold stimulation of Ins(1,3,4)P3 accumulation in the
presence of carbachol was much greater than for
Ins(1,4,5)P3.
Batty et al. (1985) have reported that stimulation of rat
cortical slices with carbachol results in the rapid
formation ofthe novel inositol phosphate, Ins(1,3,4,5)P,.
This could be formed either by the hydrolysis of
phosphatidylinositol 3,4,5-trisphosphate or by the
phosphorylation of Ins(I,4,5)P3. The latter mechanism
appears more likely, since incubation of [3H]Ins(1,4,5)P3
with cytosol from rat brain, liver or pancreas, as well as
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Fig. 7. H.p.l.c. elution of Ins(1,3,4,5)P4
[3H]Ins(1,4,5)P3 (50 pmol; 250 nM) was incubated with rat
brain cytosol for 30 s (b), with cytosol from 1321N1 cells
for 5 min (c), or without cytosol for 5 min (a). Incubations
were in the presence of 10 mM-ATP, 20 mM-MgCl2 and
100 mM-Hepes (pH 7.5) in a final volume of 0.2 ml at
37 'C. Intact 1321N1 cells (d) prelabelled with [3H]inositol
were incubated with carbachol (1 mM) for 1 min. The
reactions were terminated as described in the Materials
and methods section and the samples were applied to
h.p.l.c. A modified programme of elution for InsP3 and
InsP4 as described in the Materials and methods section
was used. The data are representative of results obtained
in three experiments.
all resulted in the formation of InsP4 (Irvine et al., 1986).
Preliminary characterization of the Ins(1,4,5)P3 kinase
involved also has been reported (Irvine et al., 1986). The
data of Batty et al. (1985) suggest that Ins(1,3,4,5)P4 is
the likely source of Ins(1,3,4)P3 through the action of a
5-phosphatase. On the basis of properties ofelution from
h.p.l.c. and enzymic conversion of exogenous
[3H]Ins(1,4,5)P3, we have tentatively identified a
radioactive species from carbachol-stimulated 1321N1
cells as Ins(1,3,4,5)P4. Its kinetics of appearance and
disappearance during hormonal challenge of 1321N1
cells are remarkably similar to those of Ins(1,3,4)P, and
Ins(1,4,5)PA. None of the work in this manuscript
directly addressed the source ofthese inositol phosphates.
However, if the precursor-product relationship of
Ins(1,4,5)P3-- Ins(1,3,4,5)P4-- Ins(1,3,4)P3 applies in
hormone-stimulated 1321N1 cells, then the kinase and
E Ins( 1,3,4,5)P4
200
0 2 4 10 30
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Fig. 8. Time course of accumulation of Ins(1,3,4)P3, Ins(1,4,5)P3
and Ins(1,3,4,5)P4 in carbachol-stimulated 1321N1 cells
Cells were labelled overnight with 10 ,tCi of
[3HJinositol/ml. The cells were incubated with carbachol
(1 mM) in the absence of LiCl, and the reaction was
terminated by 0.5 ml of 5% trichloroacetic acid. InsP3
isomers and InsP4 were separated by h.p.l.c. as described
in the Materials and methods section. Data are means
+S.E.M. for three dishes; similar results were obtained in
two separate experiments. Ins(1,4,5)P3 (0, *), Ins-
(1,3,4)P3 (L, A) and Ins(1,3,4,5)P4 (O, *) accumulations
in the absence (0, L/, l) or presence (@, A, U) of
carbachol are shown.
phosphatase involved must be very active. It is
important to note that in preliminary experiments with
washed membranes from 1321N1 cells (N. Nakahata &
T. K. Harden, unpublished work), carbachol in the
presence of guanosine 5'-[y-thio]triphosphate stimulated
the formation of Ins(1,4,5)P,, but not Ins(l,3,4,5)P4 or
Ins(1,3,4)P,. One explanation for this result would be the
loss in a membrane preparation of the contribution of
a soluble kinase that converts Ins(1,4,5)P3 into
Ins(l,3,4,5)P4. Two other radioactive species from
1321N1 cells are also eluted at very high ammonium
formate molarities during h.p.l.c. ion-exchange chroma-
tography (N. Nakahata & T. K. Harden, unpublished
work). The elution properties of these species are similar
to that expected for InsP, and InsP6 (Heslop et al., 1985);
however, stimulation of 1321N1 cells with carbachol or
histamine has no effect on the amounts of these two
compounds.
Although both muscarinic- and histamine-receptor
activation results in inositol phosphate formation in
1321NI cells, the properties of these responses are
markedly different. The initial rates of carbachol- or
histamine-stimulated accumulation, measured either as
total inositol phosphates or as Ins(1,4,5)P3 and
Ins(1,3,4)P3 accumulation, were similar. However, the
accumulation of InsP3 isomers in the presence of
carbachol reached a steady state that was maintained for
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up to 60 min, whereas both InsP3 isomers returned to
control values within 5 min of exposure to histamine.
Changes in the amounts of total inositol phosphates in
response to the two agonists reflected these marked
differences in the production of InsP3. Since re-addition
of histamine after 5-10 min had no further effect on
inositol phosphate formation, the results indicate that
the response of 1321N1 cells to histamine is rapidly
desensitized, whereas, as has been previously demon-
strated by Masters et al. (1985a), the muscarinic-receptor-
mediated response does not. Although agonist-occupied
H1-histamine (Nakahata et al., 1986) and muscarinic
(Hughes et al., 1984; Evans et al., 1985; Martin et al.,
1985; Masters et al., 1985b) receptors apparently interact
with the same population of G-protein, which is coupled
to phospholipase C and is not a pertussis-toxin
substrate, preincubation of 1321 NI cells with histamine
does not decrease the subsequent capacity of carbachol
to stimulate the accumulation of inositol phosphates.
Thus the simplest interpretation of the results is that
histamine responses are selectively modified at the level
of the histamine receptor or at the level of interaction
of this receptor with the putative guanine nucleotide
regulatory protein involved in coupling hormone recep-
tors to phospholipase C. No evidence for agonist-induced
functional modification of the muscarinic receptor, other
than receptor down-regulation after long-term exposure
to carbachol, has been detected in 1321N1 cells (Masters
et al., 1985a; Harden et al., 1985).
Although homologous desensitization ofthe histamine
receptor response apparently occurs at the level of the
plasma membrane, and the effects of muscarinic-receptor
stimulation on inositol phosphate formation do not
decrease for up to 60 min, responsiveness measured at
subsequent steps rapidly declines for both agonists in a
heterologous manner (Masters et al., 1985a; Harden
et al., 1986). That is, the Ca2+-mobilizing response as well
as the response to carbachol and histamine of Ca2+-
calmodulin-regulated cyclic AMP phosphodiesterase are
rapidly lost after treatment with carbachol. Depletion of
a hormone-sensitive Ca2+ pool or desensitization of
InsP3 'receptors' could account for heterologous desen-
sitization occurring at a step after inositol phosphate
formation.
In conclusion, carbachol as well as histamine stimu-
late the formation of compounds tentatively identified
as Ins(1,4,5)P3, Ins(1,3,4,5)P4 and Ins(1,3,4)P3. Since
the rates of appearance and disappearance of all
three compounds are very similar in 1321N1 cells,
the kinase and phosphatase involved must be very
active if the precursor-product relationship of
Ins(1,4,5)P3-- Ins(1,3,4,5)P4-- Ins(1,3,4)P3 applies. H1-
Histamine-receptor-mediated, but not muscarinic-
receptor-mediated, inositol phosphate formation is
rapidly desensitized in 1321N1 cells. Application of
newly developed methodology for the analysis of
phosphoinositide turnover in cell-free preparations from
1321N1 cells (Hepler & Harden, 1986) should allow
identification of the level at which the regulation of the
muscarinic- and histamine-receptor responses differ.
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